Glaukos Corporation (GKOS) Tops Q3 EPS by 39c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to Glaukos Corporation (GKOS) Tops Q3 EPS by 39c

Glaukos Corporation Announces Third Quarter 2020 Financial Results

November 5, 2020 4:10 PM EST

SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the third quarter ended September 30, 2020. Key highlights include:

Net sales of $64.8 million in Q3 2020, compared to $58.5 million in Q3 2019. Glaucoma net sales of $51.9 million and Corneal Health net sales of $12.9 million in Q3 2020. Gross margin of approximately 72% and non-GAAP gross margin of approximately 85% in Q3 2020. Operating expenses of $59.3 million and... More